SKGQA, a Peptide Derived from the ANA/BTG3 Protein, Cleaves Amyloid-β with Proteolytic Activity
Biomolecules · 15.05.2024 · 14 (5) · 586
DOI: 10.3390/biom14050586 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomolecules, online erschienen am 15.05.2024. Verfasst von Yusuke Hatakawa und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bio-Analytical Chemistry, Graduate School of Pharmaceutical Sciences, Tohoku University, 6-3 Aramaki-Aoba, Aoba-ku, Sendai 980-8578, Mi…. Hauptthemen laut MEDLINE: Amyloid beta-Peptides, Proteolysis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science, Japan Agency for Medical Research and Development, The Kochi Shimbun and Kochi Broadcasting.
Abstract (Originalsprache)
Despite the extensive research conducted on Alzheimer’s disease (AD) over the years, no effective drug for AD treatment has been found. Therefore, the development of new drugs for the treatment of AD is of the utmost importance. We recently reported the proteolytic activities of JAL-TA9 (YKGSGFRMI) and ANA-TA9 (SKGQAYRMA), synthetic peptides of nine amino acids each, derived from the Box A region of Tob1 and ANA/BTG3 proteins, respectively. Furthermore, two components of ANA-TA9, ANA-YA4 (YRMI) at the C-terminus end and ANA-SA5 (SKGQA) at the N-terminus end of ANA-TA9, exhibited proteolytic activity against amyloid-β (Aβ) fragment peptides. In this study, we identified the active center of ANA-SA5 using AEBSF, a serine protease inhibitor, and a peptide in which the Ser residue of ANA-SA5 was replaced with Leu. In addition, we demonstrate the proteolytic activity of ANA-SA5 against the soluble form Aβ42 (a-Aβ42) and solid insoluble form s-Aβ42. Furthermore, ANA-SA5 was not cytotoxic to A549 cells. These results indicate that ANA-SA5 is a promising Catalytide and a potential candidate for the development of new peptide drugs targeting Aβ42 for AD treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Bio-Analytical Chemistry, Graduate School of Pharmaceutical Sciences, Tohoku University, 6-3 Aramaki-Aoba, Aoba-ku, Sendai 980-8578, Miyagi, Japan.
- O-Force Co., Ltd., 3454 Irino Kuroshio-cho, Hata-gun 789-1931, Kochi, Japan.
- Department of Pharmacology, Kochi Medical School, Kochi University, Kohasu, Oko-cho, Nankoku 783-8505, Kochi, Japan.
- Department of Integrative Pharmacy, Faculty of Pharmaceutical Sciences, Setsunan University, 45-1 Nagaotoge-cho, Hirakata 573-0101, Osaka, Japan.
- Laboratory of Medicinal and Biochemical Analysis, Faculty of Pharmaceutical Sciences, Hiroshima International University, 5-1-1 Hirokoshinkai, Kure 737-0112, Hiroshima, Japan.
- The Institute of Prophylactic Pharmacology, 1-58, Rinku-oraikita, Izumisano 598-8531, Osaka, Japan.
ORCID-Profile: Rina Nakamura, Toshifumi Akizawa, Motomi Konishi, Fumiaki Ito
Förderung
- Japan Society for the Promotion of Science
- Japan Agency for Medical Research and Development
- The Kochi Shimbun and Kochi Broadcasting
- AMED
- Charitable Trust “Fund of Life (Inochi)”—The Kochi Shimbun and Kochi Broadcasting
Zitieren
APA
Hatakawa, Y., Nakamura, R., Akizawa, T., Konishi, M., Matsuda, A., Oe, T., Saito, M., & Ito, F. (2024). SKGQA, a Peptide Derived from the ANA/BTG3 Protein, Cleaves Amyloid-β with Proteolytic Activity. Biomolecules, 14(5), 586. https://doi.org/10.3390/biom14050586
Vancouver
Hatakawa Y, Nakamura R, Akizawa T, Konishi M, Matsuda A, Oe T, et al. SKGQA, a Peptide Derived from the ANA/BTG3 Protein, Cleaves Amyloid-β with Proteolytic Activity. Biomolecules. 2024;14(5):586. doi:10.3390/biom14050586
BibTeX
@article{Hatakawa2024,
author = {Hatakawa, Yusuke and Nakamura, Rina and Akizawa, Toshifumi and Konishi, Motomi and Matsuda, Akira and Oe, Tomoyuki and Saito, Motoaki and Ito, Fumiaki},
title = {SKGQA, a Peptide Derived from the ANA/BTG3 Protein, Cleaves Amyloid-β with Proteolytic Activity},
journal = {Biomolecules},
year = {2024},
volume = {14},
number = {5},
pages = {586},
doi = {10.3390/biom14050586}
}
EUVIMED